Q4 2021 Holdings
Filed 2022-02-11 | 116 holdings | $224.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $217.1K | 389,971 | 0.1% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $223.1K | 663,216 | 0.1% |
| Amazon COM Inc(AMZN)Call | COM | 023135106 | $233.4K | 70,000 | 0.1% |
| Merck & Co Inc(MRK)Call | COM | 58933Y105 | $256.4K | 3,345,000 | 0.1% |
| Abbvie Inc(ABBV)Call | COM | 00287Y109 | $274.2K | 2,025,000 | 0.1% |
| Select Sector Spdr TR(XLV)Call | SBI HEALTHCARE | 81369Y209 | $619.9K | 4,400,000 | 0.3% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $778.0K | 200,000 | 0.3% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $1.0M | 3,908 | 0.4% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $1.2M | 135,000 | 0.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.6M | 10,200 | 1.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $5.0M | 21,000 | 2.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.1M | 30,000 | 2.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $6.4M | 151,000 | 2.9% |
| Avantor Inc(AVTR) | COM | 05352A100 | $10.1M | 240,000 | 4.5% |
| Centene Corp del(CNC) | COM | 15135B101 | $12.8M | 155,000 | 5.7% |
| D R Horton Inc(DHI) | COM | 23331A109 | $172.8M | 1,593,008 | 76.9% |